SAVA Cassava Sciences, Inc. Stock Quote

SAVA [NASD]

Index	-	P/E	-	EPS (ttm)	-1.52	Insider Own	4.70%	Shs Outstand	40.02M	Perf Week	16.47%
Market Cap	2.14B	Forward P/E	-	EPS next Y	-1.51	Insider Trans	6.54%	Shs Float	37.38M	Perf Month	67.84%
Income	-60.60M	PEG	-	EPS next Q	-0.48	Inst Own	25.30%	Short Float	33.59%	Perf Quarter	47.36%
Sales	-	P/S	-	EPS this Y	-238.70%	Inst Trans	-4.11%	Short Ratio	3.62	Perf Half Y	9.65%
Book/sh	5.46	P/B	8.03	EPS next Y	22.20%	ROA	-23.90%	Target Price	69.00	Perf Year	-32.54%
Cash/sh	4.03	P/C	10.87	EPS next 5Y	-	ROE	-24.80%	52W Range	13.84 - 100.00	Perf YTD	0.32%
Dividend	-	P/FCF	-	EPS past 5Y	18.40%	ROI	-	52W High	-56.16%	Beta	0.19
Dividend %	-	Quick Ratio	23.40	Sales past 5Y	-	Gross Margin	-	52W Low	216.76%	ATR	5.19
Employees	24	Current Ratio	23.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	62.63	Volatility	21.00% 13.19%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-276.50%	Profit Margin	-	Rel Volume	1.74	Prev Close	46.18
Shortable	No	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	3.47M	Price	43.84
Recom	2.50	SMA20	30.28%	SMA50	64.52%	SMA200	35.92%	Volume	6,021,238	Change	-5.07%

Jul-15-21

Downgrade

Cantor Fitzgerald

Overweight → Neutral

$100

Jul-07-21

Reiterated

Maxim Group

Buy

$80 → $190

Apr-27-21

Initiated

B. Riley Securities

Buy

$78

Feb-16-21

Reiterated

H.C. Wainwright

Buy

$20 → $66

Oct-23-20

Initiated

Cantor Fitzgerald

Overweight

$24

Sep-23-20

Upgrade

H.C. Wainwright

Neutral → Buy

$20

May-18-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-15-20

Downgrade

Maxim Group

Buy → Hold

Jan-10-20

Reiterated

Maxim Group

Buy

$3 → $12

Sep-23-22 04:11PM	Cassava Plummets After Refuting New Claims Around Data Tampering Investigation Investor's Business Daily -18.00%
01:43PM	Pain Therapeutics Stock Shows Rising Price Performance With Jump To 97 RS Rating Investor's Business Daily
09:19AM	10 Most Shorted Stocks in September Insider Monkey
Sep-16-22 06:15PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know Zacks
Sep-09-22 12:08PM	16 Best Penny Stocks to Buy Now Insider Monkey +10.77%
09:15AM	Loading…
Sep-08-22 09:15AM	Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference GlobeNewswire
Sep-05-22 08:01PM	Strong Insider Buying Makes These 2 Stocks Attractive TipRanks
Aug-18-22 01:06PM	Cassava Insiders Got A Lot Richer As Shares Rebound Following Refutation of Data Manipulation Claims Benzinga
09:15AM	No Evidence of Data Manipulation in Science Publication on Simufilam GlobeNewswire
Aug-17-22 01:40PM	Cassava Sciences, Blue Apron, and Revlon Stocks Exploded Out of the Gate Wednesday Morning Motley Fool +27.26%
Aug-16-22 06:09PM	Top after-hours movers: Apple, Cassava Sciences, Canoo, Digital World Acquisition Corp. Yahoo Finance
05:10PM	Stocks to watch: Apple, Digital World Acquistion Corp, Cassava Science, Canoo Yahoo Finance Video
Aug-03-22 09:15AM	Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study GlobeNewswire
Jul-29-22 01:29PM	10 Stocks to Sell Before They Die InvestorPlace
Jul-27-22 02:58PM	Cassava's stock dives 21% after report citing alleged criminal probe of data from Alzheimer's drug trial MarketWatch -13.95%
01:36PM	Loading…
01:36PM	Cassava Sciences Responds to Media Reports GlobeNewswire
10:08AM	We're Not Very Worried About Cassava Sciences' (NASDAQ:SAVA) Cash Burn Rate Simply Wall St.
07:10AM	Cassava Sciences Shares Plunge After Criminal Investigation Report Benzinga
06:05AM	Exclusive-Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say Reuters
Jul-26-22 06:15PM	Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know Zacks
Jul-24-22 10:00AM	7 Meme Stocks Trading at a Massive Discount Right Now InvestorPlace
Jun-24-22 06:15PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
Jun-16-22 06:15PM	Cassava Sciences, Inc. (SAVA) Stock Moves -1.38%: What You Should Know Zacks
May-25-22 11:32AM	The 7 Best Meme Stocks to Buy Now InvestorPlace +6.30%
May-05-22 09:00AM	Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program GlobeNewswire
May-04-22 08:48AM	Cassava Sciences May Be Heading Below $10 Per Share InvestorPlace
Apr-29-22 02:40PM	Stay Far Away From Cassava Sciences Amid Data Integrity Criticisms InvestorPlace
Apr-28-22 05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
Apr-26-22 03:03PM	Take Full Advantage of Weakness in Cassava Sciences Stock InvestorPlace
Apr-25-22 03:11PM	Cassava Sciences Is a Worthwhile Bet to Consider InvestorPlace +8.42%
09:00AM	Loading…
09:00AM	Cassava Sciences Invited to Participate in B. Riley Securities Neuroscience Conference GlobeNewswire
Apr-19-22 03:17PM	Cassava Sciences (NASDAQ:SAVA) has More Than Enough Funding to Function Until the Approval Process is Finished, but Investors may Need to be Ready for a Long Wait Simply Wall St. -11.26%
Apr-15-22 09:30AM	10 Meme Stocks Redditors are Buying in April Insider Monkey
Apr-14-22 07:14PM	Top Sports Betting Stocks for Q2 2022 Investopedia
Apr-11-22 05:04PM	Cassava Sciences Is Worth Considering After Hitting Its Latest Trough InvestorPlace
03:49PM	Is There An Opportunity With Boyd Gaming Corporation's (NYSE:BYD) 41% Undervaluation? Simply Wall St.
Apr-08-22 08:59AM	Biogen (BIIB) Down as Medicare Limits Coverage for Aduhelm Zacks
Apr-07-22 05:29PM	Cassava Stock: Despite Overhangs, the Risk-Reward Looks Appealing, Says Analyst TipRanks
Apr-06-22 06:11PM	Top 10 Stocks Billionaire David Einhorn Just Added to His Portfolio Insider Monkey -6.50%
Apr-04-22 06:00PM	Cassava Sciences, Inc. (SAVA) Outpaces Stock Market Gains: What You Should Know Zacks
09:00AM	Webcast Details for Cassava Sciences Upcoming Fireside Chat GlobeNewswire
Apr-01-22 11:37AM	Here's Why Cassava Sciences Stock Could Make a Comeback Motley Fool
Mar-30-22 06:18PM	Risk-on Biotech Investors Should Buy Cassava Sciences InvestorPlace
09:00AM	Cassava Sciences Announces Fireside Chat and Presentation Tuesday, April 5th GlobeNewswire
Mar-25-22 06:00PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-18-22 05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-15-22 01:33PM	Keep Risk in Mind With Cassava Sciences Stock, but Dont Dismiss Upside Potential InvestorPlace +6.90%
Mar-10-22 06:00PM	Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know Zacks
Mar-04-22 05:50PM	Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know Zacks
08:48AM	Implied Volatility Surging for Cassava Sciences (SAVA) Stock Options Zacks
Mar-03-22 04:45PM	Cassava Sciences Is in a Bleak Midwinter Waiting for Spring and Better Days InvestorPlace -8.64%
Mar-01-22 04:41PM	Cassava: Making Big Things Happen? This 5-Star Analyst Thinks So TipRanks -5.50%
Feb-28-22 04:03PM	Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates GlobeNewswire
Feb-25-22 05:50PM	Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know Zacks
01:17PM	Why Cassava Sciences Is Still a High-Risk Play InvestorPlace
Feb-18-22 03:01PM	10 Most Shorted Stocks Right Now Insider Monkey
Feb-17-22 01:35PM	We're Hopeful That Cassava Sciences (NASDAQ:SAVA) Will Use Its Cash Wisely Simply Wall St. -7.77%
Feb-15-22 05:50PM	Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know Zacks
Feb-11-22 10:53AM	This Analyst Goes Back to the Future to Recommend Cassava Stock TipRanks
Feb-10-22 04:07PM	FDA Denies Citizen Petitions Filed on Behalf of Short Selling Clients GlobeNewswire +7.78%
Feb-08-22 05:50PM	Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know Zacks
05:30PM	Does Cassava Sciences and Its Alzheimers Drug Really Have What It Takes? InvestorPlace
08:05AM	NASDAQ: SAVA Investor Notice: Update in Lawsuit against Cassava Sciences, Inc. announced by the Shareholders Foundation ACCESSWIRE
Feb-07-22 01:41PM	Keep an Eye on $60 as a Target Price for Cassava Sciences InvestorPlace
Feb-04-22 12:32PM	These companies saw the largest market-cap gains during the pandemic American City Business Journals +6.06%
Feb-03-22 10:27AM	The End Result May Be Worth the Wait With Cassava Sciences Stock InvestorPlace
Feb-02-22 05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-31-22 05:38PM	Dumont & Blake Investment Advisors Llc Buys Cassava Sciences Inc, PRA Group Inc, Corteva ... GuruFocus.com +11.32%
Jan-28-22 01:38PM	Bellwether Advisors, LLC Buys Financial Select Sector SPDR, Consumer Discretionary Select ... GuruFocus.com +5.55%
Jan-26-22 06:00PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know Zacks
Jan-24-22 03:02PM	Cassava Sciences Is an Exciting Roll-the-Dice Biotech Trade InvestorPlace +8.84%
Jan-21-22 01:38PM	Kestra Private Wealth Services, Llc Buys FT Cboe Vest Fund of Deep Buffer ETFs, iShares Core U. ... GuruFocus.com
Jan-18-22 02:57PM	Top Biotech Stocks for Q1 2022 Investopedia -9.59%
02:07PM	Cassava Sciences Stock Is Still Risky but Has Plenty of Upside Potential InvestorPlace
Jan-12-22 04:16PM	Cassava: An Attractive Value Proposition TipRanks
10:34AM	Biogen (BIIB) Down on Medicare Draft Ruling for Alzheimer's Drugs Zacks
Jan-10-22 01:45PM	Cassava Sciences Stock Is Worth Almost 4x More After Adjusting for Risk InvestorPlace
Jan-07-22 01:26PM	Top Small Cap Stocks for January 2022 Investopedia
07:22AM	Where Will Cassava Sciences Be in 1 Year? Motley Fool
Jan-04-22 11:30AM	3 Healthcare Stocks That Could Rocket Higher in 2022 Motley Fool
Dec-31-21 08:42AM	Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock? Zacks
Dec-30-21 06:00AM	7 of the Best Meme Stocks for 2022 to Buy Now InvestorPlace
Dec-23-21 09:00AM	Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam in Alzheimers Disease GlobeNewswire
Dec-22-21 02:15PM	Cassava Stock to Hit $215? This Analyst Thinks Its Possible TipRanks
Dec-21-21 05:40PM	SAVA Stock Alert: What Is Going on With Red-Hot Cassava Sciences Today? InvestorPlace +18.77%
03:01PM	Science Journal Finds No Evidence To Data Manipulation By Cassava Sciences' In 2005 Publication Benzinga
12:16PM	Biogen (BIIB) to Cut Alzheimer's Drug Aduhelm Price by 50% Zacks
10:33AM	SAVA Stock: The Social Media Chatter That Has Cassava Sciences Trending Today InvestorPlace
09:30AM	Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Publication GlobeNewswire
06:38AM	Cassava Surges on Claim Another Science Journal Cleared it of Charges Investing.com
Dec-18-21 05:51AM	3 Stocks That Turned $200,000 Into $1 Million (or More) in 2021 Motley Fool
Dec-04-21 01:56PM	CORRECTING and REPLACING CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm Business Wire
Dec-03-21 12:59PM	While Cassava Sciences Is a Risky Play, It Has Substantial Payoff Potential InvestorPlace -5.17%
Dec-02-21 06:55AM	Should Investors Worry About the Federal Investigation of Cassava? Motley Fool
Nov-27-21 01:18PM	10 Meme Stocks that More than Doubled in 2021 Insider Monkey
Nov-26-21 09:34AM	Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock? Zacks
Nov-22-21 11:00AM	Cassava Sciences Just Returned to the Buy Zone InvestorPlace
Nov-19-21 08:59AM	Cassava Sciences faces increased scrutiny of Alzheimer's drug, presses ahead with advanced trials American City Business Journals +9.81%
Nov-18-21 02:27PM	Cassava Sciences Kickstarts Second Late-Stage Alzheimer's Trial With Simufilam Benzinga
10:36AM	Biogen's (BIIB) Aducanumab Gets CHMP's Negative Trend Vote Zacks

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBERTSON SANFORD	Director	Sep 08	Option Exercise	23.59	2,802	66,099	1,027,567	Sep 12 04:00 PM
Kupiec James William	Chief Clinical Dev. Officer	Aug 23	Buy	24.44	2,500	61,100	2,500	Aug 24 04:02 PM
Barry Richard	Director	Aug 23	Buy	23.79	36,159	860,223	186,159	Aug 25 04:20 PM
Schoen Eric	Chief Financial Officer	Aug 12	Buy	19.95	2,500	49,875	19,800	Aug 16 04:28 PM
ROBERTSON SANFORD	Director	Aug 12	Buy	20.69	100,000	2,069,000	1,024,765	Aug 16 04:24 PM
BARBIER REMI	President and CEO	Jun 06	Option Exercise	23.38	65,368	1,528,304	822,437	Jun 07 06:24 PM
FRIEDMANN NADAV	Chief Medical Officer	May 27	Option Exercise	23.38	28,014	654,967	95,103	May 31 04:20 PM
BARBIER REMI	President and CEO	Apr 25	Option Exercise	2.40	49,460	118,703	376,112	Apr 25 06:29 PM
GUSSIN ROBERT Z	Director	Mar 29	Option Exercise	21.53	7,470	160,856	12,434	Mar 29 07:20 PM
ROBERTSON SANFORD	Director	Mar 25	Option Exercise	20.30	4,670	94,801	924,765	Mar 28 05:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience